Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy

Chitra Lal; Charlie Strange

doi:10.2147/COPD.S114273

open access to scientific and medical research

Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 12

Review

Spotlight on fluticasone furoate/umeclidinium/vilanterol in COPD: design, development, and potential place in therapy

Total article views		HTML views	PDF downloads	Totals
8,762	Dovepress*	6,164+	1,847	8,011
	PubMed Central*	2,598	579	3,177
	Totals	8,762	2,426	11,188
*Since 30 December 2016

View citations on PubMed Central and Google Scholar

In order to provide our website visitors and registered users with a service tailored to their individual preferences we use cookies to analyse visitor traffic and personalise content. You can learn about our use of cookies by reading our Privacy Policy. We also retain data in relation to our visitors and registered users for internal purposes and for sharing information with our business partners. You can learn about what data of yours we retain, how it is processed, who it is shared with and your right to have your data deleted by reading our Privacy Policy.

If you agree to our use of cookies and the contents of our Privacy Policy please click 'accept'.